Edition:
United Kingdom

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

16.91USD
19 Jan 2018
Change (% chg)

$0.26 (+1.56%)
Prev Close
$16.65
Open
$16.65
Day's High
$17.05
Day's Low
$16.65
Volume
30,866
Avg. Vol
86,101
52-wk High
$17.95
52-wk Low
$9.90

Chart for

About

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company... (more)

Overall

Beta: 2.41
Market Cap(Mil.): $484.84
Shares Outstanding(Mil.): 33.96
Dividend: 0.01
Yield (%): 0.34

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

05 Jan 2018

BRIEF-Invacare Announces North America Reduction In Force As Part Of Continued Cost Realignment

* INVACARE ANNOUNCES NORTH AMERICA REDUCTION IN FORCE AS PART OF CONTINUED COST REALIGNMENT

07 Dec 2017

BRIEF-Invacare announces departure of Chief Financial Officer

* Invacare Corp - ‍while co performs executive search to identify successor to Gudbranson, Kathleen P. Leneghan will assume role of interim CFO​ Source text for Eikon: Further company coverage:

02 Nov 2017

BRIEF-Invacare says ‍Alber GMBH received warning letter from US food and drug administration​

* Invacare Corp - ‍alber GMBH, a wholly owned subsidiary of Invacare Corporation, received warning letter from United States Food And Drug Administration​

25 Sep 2017

BRIEF-Invacare Q2 loss per share $0.72

* Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

07 Aug 2017

BRIEF-Invacare says will transfer production of wheelchairs to France

* Invacare - will transfer production of Invacare Rea manual wheelchairs from facility in Sweden to manufacturing facility in Fondettes, France by Jan. 2018

28 Jul 2017

BRIEF-Invacare reaches new consent decree milestone

* Invacare says received notice from FDA that co has successfully satisfied requirements to resume full operations at its manufacturing facility in Elyria, Ohio

25 Jul 2017

Earnings vs. Estimates